In our laboratory, we focus on the heterogeneity of endothelial cells. From this point of view, multiple angiogenic mechanisms can additionally be observed too. Our data indicate differences in phenotypes of endothelial cells in certain areas of lung. For example, we have found that the expression of thrombomodulin (TM) in pulmonary endothelial cells is present in alveolar capillary endothelial cells, but absent in microvessels located in peribronchial connective tissue. 2, 3 Relevant to angiogenesis, the alveolar capillary endothelial cells lose TM expression pattern in highly vascularized tumors, ie pulmonary adenocarcinoma. Since the functional involvement of TM in cell growth has been shown, 4, 5 TM may play some part in lung angiogenesis that is supposed to be tissue-site specific. Thus, the existence of multiple signal pathways in vascular formation is highly feasible.
Other data from our experiments on proteaseactivated receptors (PARs) further supports the concept of multiple signal involvement in vascular formation. 6 In vivo, the expression level of PARs (multi-functional G-protein coupled receptors) mRNA showed a cell type-specific nature in endothelial cells from a different origin. These heterogeneous endothelial cells responded differently to their ligands and showed different susceptibility toward DNA synthesis. 6 Since PARs may also activate cell migration in endothelial cells, these results suggest the tissue or site specificity of PAR signals during angiogenesis. This type of signal multiplicity (modulation) could also occur during the angiogenic process, indicating the requirement for further studies to unravel novel angiogenic pathways. Studies in these lines will lead to a better angiogenic therapy that could treat cancer by their type or tissue of origin. Among the novel angiogenesis-related pathways, Slit/Robo signaling is one of the most recently identified pathways which regulate the directional migration of endothelial cells during vascular formation. 7
Slit/Robo, a new vascular signal
Slit/Robo signalling was first demonstrated as an extracellular cue to guide axon pathfinding, to promote axon branching, and to control neuronal migration. 8 In this pathway, the Robo family and Slit family play as receptor and ligand, respectively. 8 The Robo gene was first isolated from Drosophila melanogaster, 9 and other Robo members (Robo1, Robo2, Robo3, and Robo4) have been cloned in different species including Caenorhabditis elegans, 10 mouse, 11 and human. 9 The Robo family is composed of immunoglobulin (Ig) and fibronectin (FN type III) motifs in extracellular domain. In cytoplasmic tail, these large transmembrane receptors have conserved cytoplasmic (CC0 to CC3) motifs ( Figure 1A ). Among four Robos, endothelial-specific Robo4 (also called magic roundabout) is distinct in that it has different numbers of conserved domains. 12 Robos are considerably large molecules and are composed of 1000 to 1600 amino acids (GenBank sequences: AF040990, XM_031246, AY509035, and BC039602). The Slit family in mammals has sequences of about 1500 amino acids (GenBank sequences: AB017167, AF133270, and AB017169), and consists of three members: Slit1, Slit2, and Slit3. 13, 14 The primary structure of Slit contains leucine-rich repeats (LRR), EGF repeats, laminin G domain, and cysteine knot in the C-terminal ( Figure 1B ). [15] [16] [17] These two characteristic Robo and Slit families participate in signaling during cell migration, and their roles have been described in the migration of the neuronal cells, 15 leukocytes, 18 and muscle precursor cells. 19 In connection with the vascular formation (angiogenesis and vasculogenesis), recent reports indicate that Robo and Slit families also regulate the cell migration in endothelial cells. In the present study, we provide an overview of the current literature on angiogenesis with reference to distinct and novel signal pathways, ie Slit/Robo signal pathways. 
Expression of Robo and angiogenesis
Among the Robo family, Robo4 was isolated as a vascular-specific receptor, and shown to be associated with angiogenesis independently by Huminiecki et al 12 Huminiecki et al was first to show the endothelialspecific expression of Robo4 at the sites of active angiogenesis. They used bioinformatics data mining to isolate novel endothelial-specific genes. 21 The combination of Gene/EST screen with SAGEmap xProfiler differential analysis revealed Robo4, which contains a region of similarity to the intracellular domain of human Robo1. Expression of Robo4 was observed by ribonuclease protection analysis, and was detected in human umbilical vein endothelial cells (HUVEC), human dermal microvascular endothelial cells (HDMEC), and mammary microvascular endothelial cells (HMME2) in vitro. In contrast, the fibroblast cell line MRC-5, breast carcinoma cell line MCF-7, and neuroblastoma cell line SY-SH-5Y were negative for Robo4 expression. In addition to these data, Robo4 expression in the endothelial cell was further confirmed by Western blot analysis, and only HDMEC showed a positive expression. Interestingly, under the hypoxia condition, Robo4 expression was induced in HDMEC, suggesting its strong relation with angiogenesis. As predicted by this result, in situ hybridization analysis exhibited Robo4 expression in placental arteriole and venule, ganglioglioma, and papillary bladder carcinoma, where active angiogenesis takes place. Its expression was highly restricted, and there was no detectable signal in many tissues, including neuronal tissue. Although the expression of Robo1 in HUVEC was confirmed by Wang et al, 7 Robo4 seems to be the key player that regulates angiogenesis.
In the experiments of Park et al., 20 Robo4 expression was shown in embryonic and adult murine vasculatures. Their work on Robo4 started from studies on activin receptor-like kinase 1 (Alk1) Ϫ/Ϫ mice manifesting arteriovenous malformations. 22 Utilizing differential display technique (wild type vs Alk1 Ϫ/Ϫ mice), they found a fivefold increase of Robo4 mRNA expression. 20 In the normal mice, Robo4 mRNA expression was determined by in situ hybridization, and at E9.0, Robo4 mRNA was positively expressed in the dorsal aorta and intersomitic vessels. Soon, in the dorsal aorta, its expression gradually disappeared, and by E10.0, Robo4 mRNA expression expanded to smaller vessels. 20 To further investigate the expression pattern of Robo4, both Northern blot analysis and immunohistochemical staining were performed in adult tissues. Robo4 mRNA was highly expressed in the heart, moderately in the liver, kidney, and lung, and was undetectable in the brain, skeletal muscle, spleen, and testis as determined by Northern blot analysis. In the murine heart, Robo4 was expressed in the vascular endothelium and smooth muscle layer of blood vessels. Similarly, in the lung, blood vessels and smooth muscle cells at bronchi were positively stained. In the brain tissue, Robo4 was strongly expressed in the vascular smooth muscle cells and much less in the vascular endothelial cells. Together with the expression pattern of Robo4 in humans, these results indicate the possible role of Robo4 in both angiogenesis (pathologic condition) and vasculogenesis (developmental process).
Expression of Slit and angiogenesis
To date, the Slit family is the only physiologically known ligand for the Robo receptor. In humans, the Slit family is involved in: (1) neuronal axon guidance; and (2) inhibition of chemokine-induced leukocyte chemotaxis. 18 Other than these known functions, the Slit functions in the vasculature were recently reported in relation with angiogenesis. Slit2 was found in cancer cells such as A375 cells, a cell line derived from human malignant melanoma. 7 In vivo experiments indicated A375induced angiogenic response in endothelial cells which express Robo1. In other solid tumors, Slit2 expression was confirmed both by Northern blotting and immunoblotting. A wide range of cancer cell types expressed Slit2 including SCaBER (bladder squamous carcinoma), SK-N-SH (neuroblastoma), NCI-H446 (small cell lung cancer), T24 (transitional cell carcinoma of urinary bladder), LoVo (colon adenocarcinoma), ZR-75-30 (breast cancer), CNE (nasopharyngeal carcinoma), SMMC-7721 (hepatocellular carcinoma), Acc-2 (adenoid cystic carcinoma of the salivary gland), Acc-M (adenoid cystic carcinoma of the salivary gland), and A673 (rhabdomyosarcoma). 7 Also, cancerous human tissues including malignant melanoma, rectal mucinuous adenocarcinoma, breast infiltrating carcinoma, stomach squamous carcinoma, and hepatocellular carcinoma tissues were positively stained with anti-Slit2 antibody. 7 However, in some cancer cell lines, such as A549 (lung cancer), HeLa (cervical epithelial adenocarcinoma), MCF-7 (breast adenocarcinoma), and 786-0 (primary renal cell adenocarcinoma), Slit2 was not detectable. 7 This lack of Slit2 expression in cancer cells could partly be explained by the results obtained from genomic studies by Dallol et al, which indicated the inactivation (or hypermethylation of the promoter region of the CpG island) of the Slit2 gene in lung and breast cancers, gliomas, and colorectal cancer. [23] [24] [25] Taken together, these results strongly postulate the role of Slit/Robo signaling in angiogenesis and the relevant significance of Slit2 function in many angiogenic tissues.
Slit/Robo signaling and angiogenesis
The Robo and Slit expressions at the sites of angiogenic activity indicate their role in angiogenesis. Indeed, independent experiments show angiogenic properties of Robo or Slit proteins in vitro and in vivo. So far, Slit/Robo signaling has been approached from four different directions: (1) studies on Robo function; 20, 26 (2) studies on Slit function; 7 (3) studies on the unknown ligand for Robo; 27 and (4) studies on molecular signals that guide ECs migration. 28 Partly, the results from these experiments were contradictory, and the ongoing new experiments are expected to establish the specific role of the Slit/Robo signal in the process of angiogenesis. Table 1 summarizes the hitherto reported major works on Slit/Robo functions.
In the studies on Robo function by Park et al, 20 Robo4, an endothelial-specific Robo family member, was evaluated. They demonstrated the interaction of Robo4 with myc-tagged Slit2 in the immunoprecipitation assay. Furthermore, binding of Robo4 and Slit2 was confirmed immunocytochemically by applying myc-Slit2 conditioned media to Robo4 transfected human embryonic kidney-293 (HEK) cells. After the confirmation that Slit2 could be a potential Robo4 ligand, they showed that conditioned media from Slit2myc transfected HEK cells inhibited the cellular migration of HEK cells transfected with Robo4. On the other hand, control-conditioned media from HEK cells induced cell migration normally, and Slit2-mycconditioned media did not suppress the migration of control HEK cells, which had no Robo4 expression. The inhibitory effect of the Robo4 signal was also shown in human microvascular endothelial cells (HMVEC). Similar experiments using Slit2 containing conditioned medium also inhibited the migration of HMVEC. The inhibitory effect of this conditioned medium was reversed by an antibody against Slit and NRobo1 blocking a Slit and Robo interaction. Therefore, Slit2-Robo4 signaling was considered as a cell migration inhibitory signal. In vivo studies by Bedell et al reported the essential role of Robo4 during vascular development in embryonic zebrafish. 26 When morpholino (MO) phosphorodiamidate oligonucleotides against Robo4 mRNA was injected into a one-cell stage zebrafish embryo, MO knockdown zebrafish showed either a lack or abnormal shape of intersomitic vessels (ISV). Interestingly, overexpression of Robo4 did not induce ISV sprouts. The requirement for a proper expression level of Robo4 during ISV development suggests that Robo4 may be regulating vessel growth to a proper path by either attracting or repulsing cell migration.
On the other hand, Wang et al 7 have approached angiogenesis-related Slit/Robo signaling by studies on Slit function. Since a large number of solid tumors express Slit2, they searched the role of Slit2 on migration, tube formation, and angiogenesis in vivo. Directional migration was observed in Slit2-treated HUVEC, whereas random migration was induced by bFGF treatment. In relation to this migratory effect of Slit2, it also induced tubular formation on Matrigel. These cellular effects were inhibited by anti-Robo1 antibody and blocked by a soluble RoboN fragment, which indicates the involvement of the Robo family in this Slit2 signaling. Inoculating malignant melanoma cells (A375) in mouse normally induces angiogenesis in vivo. However, inoculation of A375 cells transfected with RoboN showed a reduced number of newly formed vessels. The soluble form of RoboN which lacks conserved cytoplasmic motifs to transduce signals may have blocked Slit and Robo interaction. These results implicate Slit as a positive angiogenic inducer.
The report by Suchting et al 27 has described studies on the unknown ligand for Robo. They showed that a soluble chimeric receptor Robo4Fc inhibits angiogenesis in vivo, sprouting from rat aortic ring, and cell migration of HUVEC (induced by bFGF and VEGF). 27 This Robo4Fc consisted of an extracellular domain of Robo4 tagged with the Fc region of human immunoglobulin, and it also induced cell cycle arrest at the G1/S phase. Furthermore, in addition to these analyses on angiogenesis, they tested the interaction of Fc-tagged Robo1 and Robo4 with Slit1, Slit2, and Slit3 by BiaCore analysis. Fc-tagged Robo1 interacted with all Slit proteins; however, Robo4Fc did not interact with any Slit proteins. Similar results were obtained by the immunoprecipitation analysis. 27 From these two new findings, they concluded that Slit2 may not be a ligand for Robo4, and there could be another unknown ligand for this phenomenon.
Studies by Seth et al showed the involvement of MEK, ERK, and FAK in Robo4 and Slit2 signaling. 28 In their experiments, expression of Robo4 or Slit2 containing conditioned medium inhibited HUVEC migration induced by FGF or VEGF. Under these circumstances, phosphorylation of endogenous FAK and ERK, regulators of cytoskeletal rearrangement and reorganization, were greatly reduced in Robo4transfected HUVECs. The phosphorylation of FAK was also reduced by incubating HUVECs with Slit2conditioned medium. Furthermore, the dominant active form of MEK functionally rescued the inhibitory effect of Robo4 in FGF-and VEGF-treated HUVECs. Therefore, the signaling pathway such as Ras-Raf-MEK-ERK may be involved in Robo4induced inhibition of endothelial migration that will lead to angiogenesis.
Questions to address
The functional studies on the Slit/Robo signal showed its most likely role in vascular formation. However, there are some discrepancies in results relevant to their role in cell migration, and more functional analyses are needed to answer the remaining questions. For example, it is still uncertain whether the Slit/Robo signal directs endothelial cell to induce or suppress cell migration ( Figure 2C) . In one experiment, the endothelialspecific Robo receptor, Robo4, was shown to inhibit cell migration. 20 Since Slit/Robo may act as an inducer in muscle precursor cell migration 19 and a repellent factor in neuronal migration, 29 additional information is required. Also, the interaction of Slit with Robo4 is questioned because HA-tagged Robo4 and myc-tagged Slit2 interacted with each other, but Robo4Fc (the extracellular region of Robo4 tagged with the Fc region of Ig) and myc-Slit2 did not in one experiment. This discrepancy displays the potential existence of a new ligand for endothelial-specific Robo, Robo4, which needs to be clarified (Figure 2A ). Furthermore, the expression of Robo4 in vasculatures in embryonic stages, certain adult tissues, and pathologic conditions indicate the roles of the Slit/Robo signal in both angiogenesis and vasculogenesis, and many questions in this area still remain unanswered ( Figure 2D) .
These critical questions are one of the major discordances in Slit/Robo functions, and they must be resolved in order to understand the role of the Slit/Robo signal in vascular formation. Here, studies on downstream signaling of the Slit/Robo pathway will be helpful. Decreased phosphorylation of ERK and FAK by Robo4 and Slit2 strongly suggest their inhibitory effect on endothelial cell migration. In addition to these signals, the activation state of Enabled (Ena), a downstream target of the Slit/Robo pathway, would be a good indicator to confirm the role of Robo4 since Ena is believed to cause a repellent effect on axon guidance. 30 However, during vascular development in the zebrafish embryo, both Robo4 overexpression and knockdown experiments showed an inhibitory effect of Robo4 on cell migration. 26 Questions still remain as to how Robo4 disrupts the directed guidance of vascular sprouts on a molecular basis and on an in vivo basis, and why it requires a precise expression level of Robo4 ( Figure 2B) .
As for the Slit and Robo4 interaction, BiaCore analysis by Suchting et al clearly showed no interaction between the Slit family and extracellular domain of Robo4. Because Robo4 has a distinct binding site different from other Robo family members (Figure 1 ), they may not interact with each other in physiologic or pathologic conditions. Therefore, in addition to the confirmatory experiments on their interaction, searching for the novel Robo4 interacting proteins (ligand) will be needed to clarify this problem. Furthermore, studies on all three Slit knockout mice may indirectly show the existence of interaction among them. However, the double knockout mice appear to have no vascular defects. 31 Targeted disruption of the Robo4 gene will also enhance the study on Slit/Robo vascular signals because it may implicate their importance in development, as well as in the pathologic condition. The physiological function of the Slit/Robo pathway is still an unexplored field, and differences in vasculatures at pathologic and developmental conditions may help distinguish abnormal vasculatures from the normalized vasculatures. This concept, namely normalization of tumor vasculature, is well reviewed by Jain, 32 and the Slit/Robo signal may be a beneficial target for this type of therapy. Although Slit and Robo, originally described as a neuronal guidance signal, are new members of angiogenic factors and studies on their function have just started, they are expected to have major roles in angiogenesis because the netrin receptor, another neuronal guidance signal, was reported to control the morphology of the vascular system. [33] [34] [35] The vascular signals regulate a variety of processes required to assemble the vascular tubes. In this review, vascular signals 'Slit' and 'Robo' were summarized. Current reports on these two targets imply the possible roles of the Slit/Robo signal pathway in both the pathologic condition and development process. Their roles are especially worthy in solid tumors, and they are expected to serve as future targets for anti-angiogenic therapy. Furthermore, Slit/Robo has the potential to be a selective target for the cancer therapy, since their expressions are observed only in a certain type of solid tumors, although many other tumor types occasionally express them.
Restricted targeting based on cancer type and the distinct impact of Slit/Robo on vasculatures may reduce therapeutic adverse effects on the patients. Additional studies of Robo/Slit functions will provide insights into the multiple mechanisms controlling vascular formation and may lead to new therapeutic avenues.
